某综合医院门诊酒石酸唑吡坦片处方研究  被引量:2

Analysis of prescriptions of zolpidem tartrate tablets in outpatients of a general hospital

在线阅读下载全文

作  者:张旭平[1] 陈海涛 李秦川[1] ZHANG Xu-ping;CHEN Hai-tao;LI Qin-chuan(Department of Pharmacy,Chengdu Second People's Hospital,Chengdu 610017,China;Department of Pharmacy,Chengdu Qinbaijiang District People's Hospital,Chengdu 610300,China)

机构地区:[1]成都市第二人民医院药剂科,成都610017 [2]成都市青白江区人民医院药剂科,成都610300

出  处:《中国药物依赖性杂志》2022年第2期134-137,共4页Chinese Journal of Drug Dependence

基  金:四川省基层卫生事业发展研究中心2020年立项项目(SWFZ20-Q-050)。

摘  要:目的分析某医院酒石酸唑吡坦片的使用情况,促进合理使用。方法以某医院2019年10月1日—12月31日门诊所有使用过唑吡坦片的患者为研究对象,采用患者追踪法,分析患者在研究期间所有的唑吡坦处方以及是否联合使用苯二氮[艹卓]类药物,并评价其合理性。结果该医院门诊药房共发放酒石酸唑吡坦处方2063张,涉及儿童6人,成人1391人。成年患者中有男性523人,女性868人,147人联合使用苯二氮[艹卓]类药物,59人过度使用唑吡坦。老年患者与肝功能损伤患者的唑吡坦剂量未减少。结论该医院酒石酸唑吡坦片的临床应用须加强管理,减少不当联合用药与过度使用,并针对患者的具体情况个体化给药。Objective To analyze the prescriptions of zolpidem tartrate tablets in a hospital so as to improve its rational administration.Methods The prescriptions of zolpidem tartrate tablets were collected from October 1 to December 31,2019 for data analysis,and all zolpidem prescriptions and combined use of benzodiazepines were analyzed by patient tracking method,and the rationality was evaluated.Results There were a total of 2063 prescriptions for 1397 patients,including 6 children and 1391 adults.There were 523 males and 868 females in the adult patients,147 patients used benzodiazepines in combination and 59 patients overused zolpidem.The dose of zolpidem was not reduced in elderly patients and patients with liver function impairment.Conclusion The administration of zolpidem tartrate tablets in our hospital should be strengthened to reduce the improper combination and overuse,and individualized administration should be carried out according to the specific conditions of patients.

关 键 词:唑吡坦 苯二氮[艹卓]类药物 失眠 处方分析 

分 类 号:R749[医药卫生—神经病学与精神病学]

 

参考文献:

正在载入数据...

 

二级参考文献:

正在载入数据...

 

耦合文献:

正在载入数据...

 

引证文献:

正在载入数据...

 

二级引证文献:

正在载入数据...

 

同被引文献:

正在载入数据...

 

相关期刊文献:

正在载入数据...

相关的主题
相关的作者对象
相关的机构对象